ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 186 filers reported holding ANI PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $218,000 | -67.5% | 6,726 | -59.1% | 0.01% | -81.7% |
| Q1 2020 | $670,000 | +60.3% | 16,439 | +142.5% | 0.06% | +215.8% |
| Q4 2019 | $418,000 | -21.4% | 6,778 | -7.1% | 0.02% | +5.6% |
| Q3 2019 | $532,000 | +29.4% | 7,299 | -12.1% | 0.02% | +38.5% |
| Q1 2017 | $411,000 | +47.3% | 8,300 | +80.4% | 0.01% | +85.7% |
| Q4 2016 | $279,000 | -35.3% | 4,600 | -29.2% | 0.01% | -30.0% |
| Q3 2016 | $431,000 | +3.1% | 6,500 | -47.7% | 0.01% | -9.1% |
| Q1 2016 | $418,000 | -19.1% | 12,431 | +8.6% | 0.01% | -21.4% |
| Q4 2015 | $517,000 | -22.5% | 11,451 | -32.2% | 0.01% | -39.1% |
| Q3 2015 | $667,000 | +54.0% | 16,885 | +141.9% | 0.02% | +76.9% |
| Q2 2015 | $433,000 | -43.7% | 6,981 | -43.2% | 0.01% | -48.0% |
| Q1 2015 | $769,000 | -8.8% | 12,289 | -17.8% | 0.02% | -13.8% |
| Q4 2014 | $843,000 | – | 14,948 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 367,754 | $10,911,000 | 4.08% |
| AIGH Capital Management LLC | 244,500 | $7,254,000 | 1.91% |
| Parkman Healthcare Partners LLC | 108,559 | $3,221,000 | 1.19% |
| Worth Venture Partners, LLC | 60,831 | $1,927,000 | 1.13% |
| Global Alpha Capital Management Ltd. | 323,731 | $9,605,000 | 1.04% |
| Mesirow Financial Investment Management, Inc. | 6,892 | $204,000 | 0.99% |
| MARATHON CAPITAL MANAGEMENT | 74,460 | $2,209,000 | 0.71% |
| EMERALD ADVISERS, LLC | 455,880 | $13,526,000 | 0.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 356,865 | $10,588,000 | 0.61% |
| Jackson Creek Investment Advisors LLC | 32,698 | $1,120,000 | 0.45% |